TENXTENAX THERAPEUTICS, INC.

Nasdaq tenaxthera.com


$ 3.51 $ -0.12 (-3.33 %)    

Wednesday, 24-Apr-2024 15:19:04 EDT
QQQ $ 431.01 $ 6.55 (1.54 %)
DIA $ 382.27 $ 1.39 (0.36 %)
SPY $ 508.26 $ 4.77 (0.95 %)
TLT $ 88.26 $ 0.46 (0.52 %)
GLD $ 216.60 $ 0.70 (0.32 %)
$ 3.48
$ 3.51
$ 0.00 x 0
$ 0.00 x 0
$ 3.51 - $ 3.51
$ 3.47 - $ 61.20
16,887
na
6.81M
$ 0.93
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 03-28-2024 12-31-2023 10-K
2 11-13-2023 09-30-2023 10-Q
3 08-14-2023 06-30-2023 10-Q
4 05-15-2023 03-31-2023 10-Q
5 03-31-2023 12-31-2022 10-K
6 11-10-2022 09-30-2022 10-Q
7 08-11-2022 06-30-2022 10-Q
8 05-16-2022 03-31-2022 10-Q
9 03-29-2022 12-31-2021 10-K
10 11-15-2021 09-30-2021 10-Q
11 08-16-2021 06-30-2021 10-Q
12 05-17-2021 03-31-2021 10-Q
13 03-31-2021 12-31-2020 10-K
14 11-16-2020 09-30-2020 10-Q
15 08-14-2020 06-30-2020 10-Q
16 05-15-2020 03-31-2020 10-Q
17 03-30-2020 12-31-2019 10-K
18 11-14-2019 09-30-2019 10-Q
19 08-14-2019 06-30-2019 10-Q
20 05-15-2019 03-31-2019 10-Q
21 04-01-2019 12-31-2018 10-K
22 11-14-2018 09-30-2018 10-Q
23 08-14-2018 06-30-2018 10-Q
24 05-15-2018 03-31-2018 10-Q
25 04-02-2018 12-31-2017 10-K
26 11-09-2017 09-30-2017 10-Q
27 08-09-2017 06-30-2017 10-Q
28 05-10-2017 03-31-2017 10-Q
29 03-16-2017 12-31-2016 10-K
30 11-09-2016 09-30-2016 10-Q
31 08-09-2016 06-30-2016 10-Q
32 05-10-2016 03-31-2016 10-Q
33 12-10-2015 10-31-2015 10-Q
34 09-09-2015 07-31-2015 10-Q
35 07-14-2015 04-30-2015 10-K
36 03-17-2015 01-31-2015 10-Q
37 12-15-2014 10-31-2014 10-Q
38 09-15-2014 07-31-2014 10-Q
39 07-29-2014 04-30-2014 10-K
40 03-17-2014 01-31-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 why-alcoa-shares-are-trading-higher-here-are-20-stocks-moving-premarket

Shares of Alcoa Corporation (NYSE: AA) rose sharply in today’s pre-market trading after the company reported better-than-expec...

 tenax-therapeutics-q4-eps-1184-misses-814-estimate

Tenax Therapeutics (NASDAQ:TENX) reported quarterly losses of $(11.84) per share which missed the analyst consensus estimate of...

 why-fangdd-network-group-shares-are-trading-higher-by-around-78-here-are-20-stocks-moving-premarket

Shares of Fangdd Network Group Ltd. (NASDAQ: DUO) rose sharply in today’s pre-market trading after the company announced its 2...

 roth-mkm-reiterates-buy-on-tenax-therapeutics-maintains-30-price-target

Roth MKM analyst Jonathan Aschoff reiterates Tenax Therapeutics (NASDAQ:TENX) with a Buy and maintains $30 price target.

 tenax-therapeutics-13g-filing-shows-cvi-investments-inc-reported-a-99-stake-in-the-co-as-of-february-8-2024

- SEC Filing

 crude-oil-gains-3-kellanova-posts-upbeat-results

U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite gaining around 30 points on Thursday. The Dow tr...

 why-compass-minerals-international-shares-are-trading-lower-by-around-9-here-are-other-stocks-moving-in-thursdays-mid-day-session

Shares of Compass Minerals International, Inc. (NYSE: CMP) fell sharply during Thursday’s session following downbeat results.

 dow-tumbles-over-100-points-us-initial-jobless-claims-fall-last-week

U.S. stocks traded mixed midway through trading, with the Dow Jones index falling more than 100 points on Thursday. The Dow tr...

 why-tenax-therapeutics-tenx-stock-is-getting-obliterated

Tenax Therapeutics shares are trading lower by 64.3% Thursday morning. The company announced the pricing of a public offering.

 us-stocks-mixed-disney-earnings-top-views

U.S. stocks traded mixed this morning, following the release of jobless claims data on Thursday. Following the market opening ...

Core News & Articles

 

 why-disney-shares-are-trading-higher-by-around-6-here-are-20-stocks-moving-premarket

Shares of The Walt Disney Company (NYSE: DIS) rose in today’s pre-market trading following the release of quarterly results.

 tenax-therapeutics-enrolls-first-patient-in-phase-3-level-study-evaluating-tnx-103-for-the-treatment-of-pulmonary-hypertension-in-heart-failure-with-preserved-ejection-fraction

Over 40 sites (U.S. and Canada) have agreed to participate in the LEVEL study LEVEL is a randomized, controlled Phase 3 tria...

 why-fortinet-shares-are-trading-higher-by-9-here-are-20-stocks-moving-premarket

Shares of Fortinet, Inc. (NASDAQ: FTNT) rose sharply in today’s pre-market trading after the company reported better-than-expe...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION